YAP1 and myasthenia gravis: Accordingly, by using a highly selective small-molecule compound, DMX-5804, which simultaneously inhibits MAP4K4/6/7 to inhibit cell death and augment mitochondrial function and calcium cycling24, we showed that MAP4K4/6/7 converge to inhibit YAP activity in human and mouse MG.